Articles

Researchers discuss new research on buprenorphine, the “gold standard” treatment for opioid use disorder at the APA Annual Meeting.

Buprenorphine and Its Therapeutic Potential in Psychiatric Disorders

An expert discusses the effects of long COVID on the brain at the 2022 APA Annual Meeting.

Neurological and Neuropsychiatric Complications of COVID-19

Experts discuss appropriate interventions for patients who are victims of undue influence at the 2022 APA Annual Meeting.

Cults in the Age of Influence

Experts discuss psychiatry’s role in the advancement of AI technologies at the 2022 APA Annual Meeting.

Leading the Artificial Intelligence Revolution

The 2022 APA Annual Meeting highlights the latest guidelines for these treatments, plus recommendations for updates and improvements.

Assessing Gaps and Opportunities in ECT, rTMS, and DBS Guidelines

Experts address cognitive dysfunction found in patients with long COVID at the 2022 APA Annual Meeting.

Clearing the ‘Brain Fog’ in Long COVID

Videos

Our Editor in Chief is thrilled to be live and in person at the 2022 APA Annual Meeting in New Orleans. Here's why. 

The Benefits of Being in Person at the 2022 APA Annual Meeting 

is an outpatient psychiatrist at Prisma Health-Upstate and clinical associate professor at the University of South Carolina School of Medicine, Greenville. He served on the American Psychiatric Association’s Task Force to Address Structural Racism Throughout Psychiatry, and he currently serves as the Diversity and Inclusion section editor and advisory board member for

"When we embrace humanity, everyone wins."

Embracing Humanity at the 2022 APA Annual Meeting

How do social stressors contribute to patient symptoms? 

The Importance of Psychosocial Stress Explored at the 2022 APA Annual Meeting

What are the neuropsychiatric effects of sparring in mixed martial arts? New research presented at the 2022 APA Annual Meeting elucidates the issues.     

APA